Decreased susceptibility of peripheral blood mononuclear cells from individuals heterozygous for a mutant CCR5 allele to HIV infection

Journal of Acquired Immune Deficiency Syndromes and Human Retrovirology

Volumn 19, Issue 2, 1998, Pages 145-149

  Kim, Ana ^a   Pettoello Mantovani, Massimo ^a   Goldstein, Harris ^a  

^a ALBERT EINSTEIN COLLEGE OF MEDICINE   (United States)

Author keywords

CCR5; HIV; Macrophage tropic; Nonsyncytium inducing

Indexed keywords

ALLELE; ARTICLE; DELETION MUTANT; GENETIC SUSCEPTIBILITY; HETEROZYGOSITY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INFECTION SENSITIVITY; MONONUCLEAR CELL; NONHUMAN; PRIORITY JOURNAL; VIRUS ISOLATION;

EID: 0031654634     PISSN: 10779450     EISSN: None     Source Type: Journal    
DOI: 10.1097/00042560-199810010-00007     Document Type: Article

References (32)

1. D'Souza P, Harden VA. Chemokines and HIV-1 second receptors. Nature Med 1997;2:1293-1300.
2. Feng Y, Broder CC, Kennedy PE, Berger EA. HIV-1 entry co-factor: functional cDNA cloning of a seven-transmembrane G protein-coupled receptor. Science 1996;272:872-7.
3. Deng H, Liu R, Ellmeier W, et al. Identification of a major coreceptor for primary isolates of HIV-1. Nature 1996;381:661-7.
4. Dragic T, Litwin V, Allaway GP, et al. HIV-1 entry into CD4+ cells is mediated by the chemokine receptor CC-CKR5. Nature 1996;381:667-73.
5. Choe H, Farzan M, Sun Y, et al. The chemokine receptors CCR3 and CCR5 facilitate infection by primary HIV-1 isolates. Cell 1996;85:1135-48.
6. Dorantz BJ, Rucker J, Yi Y, et al. A dual-tropic primary HIV-1 isolate that uses fusin and the -chemokine receptors CKR5, CKR3 and CKR-2b as fusion co-factors. Cell 1996;85:1149-58.
7. Schuitemaker H, Kootstra NA, de Goede RE, de Wolf F, Miedema F, Tersmette M. Monocytotropic HIV-1 variants detected in all stages of HIV infection predominantly lack T-cell line tropism and syncytium-inducing ability in primary T-cell culture. J Virol 1991; 66:1354-60.
8. Schuitemaker H, Koot M, Kootstra NA, et al. Biological phenotype of HIV-1 clones at different stages of infection: progression of disease is associated with a shift from monocytotropic to T-cell-tropic virus populations. J Virol 1992;66:1354-60.
9. Liu R, Paxton WA, Choe S, et al. Homozygous defect in HIV-1 coreceptor accounts for resistance of some multiply-exposed individuals to HIV-1infection. Cell 1996;6:367-77.
10. Samson M, Libert F, Doranz BJ, et al. Resistance to HIV-1 infection in Caucasian individuals bearing mutant alleles of the CCR-5 chemokine receptor gene. Nature 1996;382:722-5.
11. Dean M, Carrington M, Winkler C, et al. Genetic restriction of HIV-1 infection and progression to AIDS by a deletion allele of the CCR5 structural gene. Science 1996;273:1856-2.
12. Biti R, French R, Young J, Bennetts B, Stewart G. HIV-1 infection in an individual homozygous for the CCR5 deletion allele. Nat Med 1997;3:252-3.
13. Eugen-Olsen J, Iversen AK, Garred P, et al. Heterozygosity for a deletion in the CCKR-5 gene leads to prolonged AIDS-free survival and slower CD4 T-cell decline in a cohort of HIV-seropositive individuals. AIDS 1997:305-10.
14. WHO Network for isolation and characterization. HIV-1 type 1 variation in World Health Organization-sponsored vaccine evaluation sites: genetic screening, sequence analysis, and preliminary biological characterization of selected viral strains. AIDS Res Hum Retroviruses 1994;10:1327-43.
15. Gendelman HE, Orenstein JM, Martin MA, et al. Efficient isolation and propagation of human immunodeficiency virus on recombinant colony-stimulating factor-1-treated monocytes. J Exp Med 1988;167:1428-36.
16. Kollmann TR, Kim A, Pettoello-Mantovani M, et al. Divergent effects of chronic HIV-1 infection on human thymocyte maturation in SCID-hu mice. J Immunol 1995;154:907-21.
17. Goldstein H, Pettoello-Mantovani M, Kollmann TR, Calvelli TA, Rubinstein A. Inhibition of HIV-1 infection by alkylureas. AIDS 1991;5:1447-51.
18. Kinter AL, Poli G, Fox L, Hardy E, Fauci AS. HIV replication in IL-2-stimulated peripheral blood mononuclear cells is driven in an autocrine/paracrine manner by endogenous cytokines. J Immunol 1995;154:2448-59.
19. Bjorndal A, Deng H, Jansson M, et al. Coreceptor usage of primary human immunodeficiency virus type 1 isolates varies according to biological phenotype. J Virol 1997;71:7478-87.
20. Xiao L, Owen SM, Goldman I, et al. CCR5 coreceptor usage of non-syncytium-inducing primary HIV-1 is independent of phylogenetically distinct global HIV-1 isolates: delineation of consensus motif in the V3 domain that predicts CCR-5 usage. Virology 1998; 240:83-92.
21. Aarons E, Fernandez M, Rees A, McClure M, Weber J. CC-chemokine receptor 5 genotypes and in vitro susceptibility to HIV-1 of a cohort of British HIV-exposed uninfected homosexual men. AIDS 1997;11:688-9.
22. Zhang L, Huang Y, He T, Cao Y, Ho DD. HIV-1 subtype and second receptor usage. Nature 1996;383:768.
23. Rana S, Besson G, Cook DG, et al. Role of CCR5 in infection of primary macrophages and lymphocytes by macrophage-tropic strains of HIV: resistance to patient derived and prototype isolates resulting from the CCR5 mutation. J Virol 1997;71:3219-27.
24. Hoffman TL, MacGregor RR, Burger H, Mick R, Doms RW, Collman RG. CCR5 genotypes in sexually active couples discordant for human immunodeficiency virus type 1 infection status. J Infect Dis 1997;176:1093-6.
25. de Roda Husman AM, Koot M, Cornelissen M, et al. Association between CCR5 genotype and the clinical course of HIV-1 infection. Ann Intern Med 1997;127:882-90.
26. Katzenstein TL, Eugen-Olsen J, Hofmann B, et al. HIV-infected individuals with the CCR delta32/CCR5 genotype have lower HIV RNA levels and higher CD4 cell counts in the early years of the infection than do patients with the wild type. Copenhagen AIDS Cohort Study Group. J Acquir Immune Defic Syndr Hum Retrovirol 1997;16:10-14.
27. Stewart GJ, Ashton LJ, Biti RA, et al. Increased frequency of CCR-5 delta 32 heterozygotes among long-term non-progressors with HIV-1 infection. The Australian Long-Term Non-Progressor Study Group. AIDS 1997;11:1833-8.
28. Misrahi M, Teglas JP, N'Go N, et al. CCR5 chemokine receptor variant in HIV-1 mother-to-child transmission and disease progression in children. French Pediatric HIV Infection Study Group. JAMA 1998;279:277-80.
29. Morawetz RA, Rizzardi GP, Glauser D, et al. Genetic polymorphism of CCR5 gene and HIV disease: the heterozygous (CCR5/ delta CCR5) genotype is neither essential nor sufficient for protection against disease progression. Swiss HIV Cohort. Eur J Immunol 1997;27:3223-7.
30. Cohen OJ, Vaccarezza M, Lam GK, et al. Heterozygosity for a detective gene for CC chemokine receptor 5 is not the sole determinant for the immunologic and virologie phenotype of HIV-infected long-term nonprogressors. J Clin Invest 1997;100:1581-9.
31. Choe H, Farzan M, Sun Y, et al. The beta-chemokine receptors CCR3 and CCR5 facilitate infection by primary HIV-1 isolates. Cell 1996;85:1135-48.
32. Deng HK, Unutmaz D, KewalRamani VN, Littman DR. Expression cloning of new receptors used by simian and human immunodeficiency viruses. Nature 1997;388:296-300.